Donate online today. €375 funds the helpline for half a day

meningitis & septicaemia can kill in hours!

People who are faced with meningitis and septicaemia have to act fast to help save a life.

MRF welcomes US MenB applications

MRF welcomes US MenB applications

19 June 2014

Further to the news that drugs companies Novartis and Pfizer have made applications to the US Food and Drug Administration to license their meningococcal B (Men B) vaccines, our CEO Christopher Head commented:

"We welcome the news of these Men B vaccine licence applications in the US. Meningitis Research Foundation’s vision is of a world free from meningitis and septicaemia and we believe that vaccination is the way to reach our ultimate goal. In the UK we are eagerly awaiting introduction of MenB vaccine into the childhood immunisation programme and it is encouraging to see this latest progress on protecting Americans against this deadly disease"

Read more about the applications

Read our Q + A about the introduction of a MenB vaccine in the UK

Listeria at 10 days old

They discharged him warning anytime the infection could happen again

More stories
News

Search the news: